Awakenings by the Sea

Awakenings by the Sea offers residential addiction treatment at ASAM levels 3.1, 3.5, and 3.7, which means women do not have to choose between a lower-intensity residential setting and a more medically monitored one at separate facilities. All three levels exist within a single women's recovery community in Seaside, Oregon, preserving therapeutic relationships and peer continuity as clinical needs shift.

This matters in practice: a woman entering at ASAM 3.5 who later requires the structure of 3.7 — or who stabilizes to 3.1 — stays within the same program. For women evaluating long-term residential treatment rather than a one-size placement, that flexibility is a concrete differentiator in Oregon's addiction treatment landscape.

MAT is not an add-on at Awakenings by the Sea — it is embedded in the residential program and delivered by staff who hold CADC-II and QMHA-I credentials. Tabatha Christopherson, the Executive and Clinical Director, also carries a CCTP certification, reflecting clinical depth that extends beyond addiction counseling into trauma-informed practice.

For women whose recovery requires pharmacological support alongside residential structure, having MAT integrated into the same women's-only setting removes the fragmentation that can undermine early recovery. The center treats alcohol addiction and substance use disorders, and the 24-hour operational schedule means clinical support is not limited to daytime hours.

Cost is one of the most common barriers to residential treatment, and Awakenings by the Sea addresses it directly. The center accepts insurance from First Choice, Cigna, Aetna, United Health, Blue Cross Blue Shield, and TriWest, covering a wide range of Oregon residents and veterans through TriWest's network.

For women without in-network coverage or who prefer a private-pay arrangement, cash pay and financing options are available. The center's own language frames recovery as an investment — and the payment infrastructure reflects a practical effort to make residential substance abuse treatment reachable for women who are ready to commit to it.

The center's clinical foundation starts with its founder, Ann Martin, a Betty Ford clinical veteran, and extends through its current Executive and Clinical Director, Tabatha Christopherson, who holds CADC-II, QMHA-I, and CCTP credentials. Clinical staff member Marvel Hyder also carries CADC-II and QMHA-I certifications, reflecting a team built around verified addiction counseling competency.

CARF accreditation and NAATP membership provide external benchmarks for quality in women's addiction treatment. For families researching residential rehab options and weighing one center against another, those designations represent independent review of clinical and organizational standards — not self-reported claims.